Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role and Safety of Radiofrequency Ablation in the Multidisciplinary Treatment of Intrahepatic Recurrence After Colorectal Cancer Liver Metastasis Surgery

NCT06609434 is registered in ClinicalTrials.gov with Peking University Cancer Hospital & Institute as lead sponsor.

NCT NCT06609434
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06609434 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role and Safety of Radiofrequency Ablation in the Multidisciplinary Treatment of Intrahepatic Recurrence After Colorectal Cancer Liver Metastasis Surgery
Lead sponsor
Peking University Cancer Hospital & Institute
Phase
Not applicable
Overall status
Not yet recruiting
Start date
October 31, 2024
Completion date
December 31, 2026
Enrollment
111 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

colo-rectal cancer, liver metastasis